During the past decade, Acacia Network/Promesa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Acacia Network/Promesa" #1 collaborator was "Beth Israel Medical Center" with 1 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator and "New York University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Acacia Network/Promesa" are "Adherence" (1 trials), "HIV" (1 trials) and "Substance-related Disorders" (1 trials). Many other conditions were trialed in "Acacia Network/Promesa" in a lesser frequency.

Most popular intervention types in "Acacia Network/Promesa" are "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "On-site bundled rapid HIV/HCV testing" (1 trials), "Standard of care (SOC)" (1 trials) and "Text messaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "Acacia Network/Promesa" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Acacia Network/Promesa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Acacia Network/Promesa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Acacia Network/Promesa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".